|
Medical devices cure VCs' biotech blues
By Michael V. Copeland
Business 2.0 Magazine Senior Writer
Friday, May 12, 2006
SAN FRANCISCO (Business 2.0 Magazine) - Investing in healthcare
startups has long been a specialized business. It's one thing
to kick the tires on an Internet startup; you just go to the
website and start clicking away. It's another matter altogether
to try to figure out if a biotech startup really has come
up with a cure for cancer.
And the small number of biotech-savvy VCs has limited the
number of healthcare deals that get done. But medical devices
are changing that. Private equity investment in medical devices
rose 23% last year to $2.1 billion, and in the first quarter
of 2006, 70 medical device companies received $690 million
in venture investment, a 62% increase over the same period
in 2005.
These investments are on the rise because these life-sustaining
or -improving gizmos often use the same hardware and software
found in the IT world -- gear that is familiar to the large
number of VCs with engineering backgrounds. Indeed, information
technology is giving birth to a new generation of medical
devices that are doing everything from smoothing wrinkles
to easing depression.
Staying younger, longer
To understand the demand for medical devices, just listen
to the creaking knees of the baby-boom generation. There is
a huge, well-heeled population of people hitting their 50s
who want to keep up their daily routine for as long as possible.
They want to look younger, run faster, and work longer than
any generation that has come before them. And they have the
money to pay for some devices and services out of pocket.
In addition to the fact that this market is growing, venture
capitalists also like the fact that medical devices face far
fewer regulatory hurdles than drugs do, so they can be brought
to market faster and more cheaply.
"The number of people that are starting to consume this kind
of healthcare is large and is only going to increase," says
Mark Brooks, a venture capitalist at BA Venture Partners who
focuses on medical devices and healthcare services. "It's
a huge opportunity."
One area that Brooks and his firm focus on is orthopedics
-- devices and materials that replace hips, knees, hands,
feet and parts of the spine. "The spine is an incredibly hot
area right now," Brooks says.
Redwood City, Calif.-based Spinal Kinetics is a BA Ventures
investment that is developing a material that can replace
the lumbar discs in your back. San Diego-based N-Spine, which
is also developing implantable devices for the spine, recently
banked $1 million in venture funding.
Another red-hot area of medical-device investment is non-invasive
cosmetic surgery and skin care. In the U.S., people paid more
than $12.5 billion last year for cosmetic procedures out of
their own pockets. It's the sort of predictable and growing
market VCs love.
Startups in this arena that recently received funding include
DermaCare, a Livermore, Calif.-based company that landed $2.7
million to develop new skincare technologies. Palo Alto-based
Aesthetic Sciences banked $3 million for its soon-to-launch
"injectable filler" products which promise to erase, or at
least lessen, wrinkles.
There are plenty of remaining opportunities. One area that
remains largely untapped by startups, VCs say, is the intersection
between wireless technology and healthcare. As sensors and
communications networks converge to give us 24/7 health monitoring,
there will be money to be made by adapting off-the-shelf wireless
technologies to the needs of doctors and nurses.
Sad to say, even with all these new devices that will keep
us going longer than ever before, at some point we're sure
to land in the hospital -- and when we're there, we'll want
the best technology money can buy. That's what makes medical
devices such a great growth market for venture capitalists.

|